Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 26 June 2019 23:04

ImmuniWeb® AI introduces rapid testing and report delivery SLA for CI/CD

Already providing a zero false-positives SLA with money back, ImmuniWeb now offers a guaranteed schedule for rapid application security testing and report delivery.

Gartner says that application security testing (AST) market continues to be the fastest-growing segment in the information security space, estimated to reach $1.15 billion by the end of 2019.

Award-winning ImmuniWeb® AI Platform leverages Machine Learning and AI for intelligent automation and acceleration of application penetration testing. Driven by human intelligence, it rapidly detects even the most sophisticated vulnerabilities, fully covers SANS Top 25 and PCI DSS 6.5.1 – 6.5.10 security issues, and comes with a zero false-positives SLA corroborated with money back for a single false positive in a report.

Starting from today, all clients and partners will likewise benefit from rapid testing and report delivery SLA tailored for continuous integration/continuous delivery (CI/CD) and DevSecOps needs.

Available on a continuous and one-time basis, ImmuniWeb AI Platform offers all its customers the following unbeatable features at no additional cost:

- Rapid Delivery SLA - Zero False Positives SLA - Actionable Remediation Guidelines - 24/7 Access to ImmuniWeb Security Analysts - Effortless, One-Click Virtual Patching Capacities

Ilia Kolochenko, CEO and Founder of ImmuniWeb, says: “At ImmuniWeb, we are committed to delivering value and excellence to our customers and partners, supporting their journey towards safe, reliable and compliant applications. We endeavor to make this journey simple and result-oriented.

Given the growing importance of agile development and CI/CD approach, we are truly excited to offer a rapid and predictable application security testing of the highest quality and reliability. New industry-leading features are to be announced soon, please stay tuned.”

Start your application security journey with ImmuniWeb® Discovery or request your free trial today.

Submit a media release